|
United Therapeutics Corp Common
(UTHR)
|
13.8 |
$974M |
|
2.8M |
352.84 |
|
Argenx Se Sponsored ADR
(ARGX)
|
10.8 |
$762M |
|
1.2M |
615.00 |
|
Ascendis Pharma Sponsored ADR
(ASND)
|
9.9 |
$703M |
|
5.1M |
137.67 |
|
Madrigal Pharmaceuticals Common
(MDGL)
|
8.9 |
$626M |
|
2.0M |
308.57 |
|
Krystal Biotech Common
(KRYS)
|
5.8 |
$412M |
|
2.6M |
156.66 |
|
Apellis Pharmaceuticals Common
(APLS)
|
5.5 |
$390M |
|
12M |
31.91 |
|
Sarepta Therapeutics Common
(SRPT)
|
4.4 |
$311M |
|
2.6M |
121.59 |
|
Intra-cellular Therapies Common
(ITCI)
|
3.6 |
$255M |
|
3.1M |
83.52 |
|
Vera Therapeutics Common
(VERA)
|
3.4 |
$237M |
|
5.6M |
42.29 |
|
Xenon Pharmaceuticals Common
(XENE)
|
3.1 |
$222M |
|
5.7M |
39.20 |
|
Amicus Therapeutics Common
(FOLD)
|
3.1 |
$218M |
|
23M |
9.42 |
|
Avidity Biosciences Common
(RNA)
|
3.1 |
$218M |
|
7.5M |
29.08 |
|
Arrowhead Pharmaceuticals Common
(ARWR)
|
3.0 |
$209M |
|
11M |
18.80 |
|
Kymera Therapeutics Common
(KYMR)
|
2.9 |
$207M |
|
5.2M |
40.23 |
|
Moonlake Immunotherapeutics Class A Ord
(MLTX)
|
2.1 |
$150M |
|
2.8M |
54.15 |
|
Soleno Therapeutics Common
(SLNO)
|
1.6 |
$114M |
|
2.5M |
44.95 |
|
Blueprint Medicines Corp Common
(BPMC)
|
1.5 |
$103M |
|
1.2M |
87.22 |
|
Vaxcyte Common
(PCVX)
|
1.4 |
$96M |
|
1.2M |
81.86 |
|
Biomarin Pharmaceutical Common
(BMRN)
|
1.4 |
$96M |
|
1.5M |
65.73 |
|
Merus N V Common
(MRUS)
|
1.3 |
$89M |
|
2.1M |
42.05 |
|
Biocryst Pharmaceuticals Common
(BCRX)
|
1.3 |
$89M |
|
12M |
7.52 |
|
Alkermes Common
(ALKS)
|
1.0 |
$71M |
|
2.5M |
28.76 |
|
Ocular Therapeutix Common
(OCUL)
|
1.0 |
$69M |
|
8.1M |
8.54 |
|
Mannkind Corp Common
(MNKD)
|
0.8 |
$56M |
|
8.8M |
6.43 |
|
Tourmaline Bio Common
(TRML)
|
0.6 |
$45M |
|
2.2M |
20.28 |
|
Uniqure Nv Common
(QURE)
|
0.5 |
$38M |
|
2.2M |
17.66 |
|
Ultragenyx Pharmaceutical Common
(RARE)
|
0.5 |
$35M |
|
830k |
42.07 |
|
Taysha Gene Therapies Common
(TSHA)
|
0.5 |
$35M |
|
20M |
1.73 |
|
89bio Common
(ETNB)
|
0.5 |
$32M |
|
4.1M |
7.82 |
|
Monte Rosa Therapeutics Common
(GLUE)
|
0.4 |
$30M |
|
4.3M |
6.94 |
|
Syndax Pharmaceuticals Common
(SNDX)
|
0.4 |
$30M |
|
2.3M |
13.22 |
|
Iovance Biotherapeutics Common
(IOVA)
|
0.4 |
$26M |
|
3.5M |
7.40 |
|
Septerna Common
(SEPN)
|
0.4 |
$25M |
|
1.1M |
22.90 |
|
Autolus Therapeutics Sponsored ADR
(AUTL)
|
0.3 |
$23M |
|
9.9M |
2.35 |
|
Cg Oncology Common
(CGON)
|
0.3 |
$20M |
|
700k |
28.68 |
|
Kura Oncology Common
(KURA)
|
0.3 |
$20M |
|
2.3M |
8.71 |
|
Rocket Pharmaceuticals Common
(RCKT)
|
0.2 |
$15M |
|
1.2M |
12.57 |
|
Olema Pharmaceuticals Common
(OLMA)
|
0.1 |
$9.6M |
|
1.7M |
5.83 |
|
Aadi Biosciences Common
(WHWK)
|
0.1 |
$9.0M |
|
2.8M |
3.15 |